Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

TNP-470 inhibits human lung tumor growth and neovascularization

Feb. 11, 1999

Roberts enriches product pipeline with addition of RL-0903

Feb. 11, 1999

Bristol-Myers Squibb and EntreMed modify research agreement

Feb. 11, 1999

Platinum-based chemotherapy for ovarian cancer increases risk of leukemia

Feb. 11, 1999

Combination of TZT-1027 + ara-C provides synergistic antitumor activity

Feb. 10, 1999

ECyd evaluated for mechanism of action, potential clinical activity

Feb. 10, 1999

Nonpeptide GnRH antagonists claimed by Merck & Co.

Feb. 9, 1999

New photoactive agents in development at QLT and U. of British Columbia

Feb. 9, 1999

Hughes Institute enters licensing agreement for anticancer drug development

Feb. 9, 1999

Boston Life Sciences identifies a second antiangiogenic molecule

Feb. 8, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...